Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 943 (miR-943) is a single-stranded, non-coding regulatory RNA molecule found in humans. As with other microRNAs, it functions primarily by post-transcriptional repression of target messenger RNAs (mRNAs), influencing gene expression networks related to cell proliferation, apoptosis, signal transduction, and the cell cycle[2][4]. While microRNAs such as miR-943 are not classical drug targets like receptors or enzymes, they are considered promising therapeutic targets and biomarkers in various diseases, including cancer and neurodegenerative disorders, due to their broad regulatory impact on cellular processes[4]. Therapeutic strategies for microRNA modulation typically involve antisense oligonucleotides or synthetic mimics; however, no drugs are currently identified that directly target miR-943. Safety concerns in microRNA therapy center on potential off-target effects and unintended gene regulation[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 943 (miR-943).